Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix exploratory study for follicular synchronisation and endometrial receptivity in oocyte donors undergoing controlled ovarian hyperstimulation
2006-004684-58Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of degarelix and ganirelix in infertility (4 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Coefficient of variation of follicular sizes on Stimulation Day 1. Started Dec 2006; status: completed.
02
Drugs
degarelixganirelix
03
Conditions
infertility
Beyond the preview
Go deeper on 2006-004684-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004684-58.